Immunome Insider Trades: CEO Buys, CSO Sells—Pipeline & FDA Boosts Confidence
Immunome insider sales reveal routine liquidity moves, not a red flag, while CEO buying and strong antibody pipeline signal confidence in upcoming FDA milestones and growth potential.
4 minutes to read